Viewing Study NCT03448276



Ignite Creation Date: 2024-05-06 @ 11:09 AM
Last Modification Date: 2024-10-26 @ 12:41 PM
Study NCT ID: NCT03448276
Status: COMPLETED
Last Update Posted: 2019-10-22
First Post: 2018-02-02

Brief Title: Immediate Effect Of Whole-Body Vibration And Walk in OsteoporosisOsteopenia
Sponsor: Universidade Federal de Pernambuco
Organization: Universidade Federal de Pernambuco

Study Overview

Official Title: Immediate Effect Of Whole-Body Vibration And Walk Over Muscle Strength Balance And Functional Performance In Elderly People With Osteoporosis And Osteopenia Clinical Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2019-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Introduction Osteoporosis and Osteopenia are common bone disorders characterized by low bone mass signs of bone deterioration and are responsible for typical bone fragility Physical activity is certainly a valid prevention tool because it contributes to a healthy energy balance increasing muscle mass and providing beneficial effects in bone metabolism Stress induced by more vigorous activities such as weight lifting increases the risk of injury particularly in the elderly Therefore alternative strategies with lower risk of injury are indicated such as whole body vibration and walk

Objective Compare the effect whole body vibration and walking on muscular strength balance and functional performance in the elderly with Osteoporosis and Osteopenia

Methods It is a clinical trial study controlled parallel randomized and blind which will follow the guidelines established in the Consolidated Standards of Reporting Trials CONSORT Participants will be randomly distributed in 2 groups the experimental group GI that will hold the training in the vibrating platform and the control group GC that will perform the walk settling 1 treatment session All participants will be subjected to the initial and final assessment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
CAAE N 80679117500005208 OTHER UFPE None